APM [NASD]
Aptorum Group Limited
Index- P/E- EPS (ttm)-0.72 Insider Own31.67% Shs Outstand35.79M Perf Week2.80%
Market Cap41.62M Forward P/E- EPS next Y-0.71 Insider Trans0.00% Shs Float9.12M Perf Month-10.32%
Income-25.00M PEG- EPS next Q- Inst Own4.30% Short Float1.12% Perf Quarter-22.54%
Sales1.50M P/S27.75 EPS this Y-457.20% Inst Trans-8.70% Short Ratio0.86 Perf Half Y-40.86%
Book/sh0.66 P/B1.67 EPS next Y- ROA-82.70% Target Price15.00 Perf Year-60.14%
Cash/sh0.22 P/C5.01 EPS next 5Y- ROE-85.80% 52W Range0.86 - 3.50 Perf YTD-26.67%
Dividend- P/FCF- EPS past 5Y- ROI-81.10% 52W High-68.57% Beta0.11
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin5.30% 52W Low28.61% ATR0.12
Employees26 Current Ratio2.90 Sales Q/Q200.00% Oper. Margin- RSI (14)47.47 Volatility9.31% 13.23%
OptionableNo Debt/Eq0.00 EPS Q/Q24.20% Profit Margin- Rel Volume2.00 Prev Close1.05
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume118.61K Price1.10
Recom2.00 SMA206.31% SMA50-14.90% SMA200-41.74% Volume237,460 Change4.76%
May-17-22 08:13AM  
May-09-22 11:41AM  
May-02-22 08:00AM  
Apr-29-22 04:00PM  
Apr-25-22 09:30AM  
Apr-22-22 08:00AM  
Apr-06-22 07:00AM  
Mar-22-22 05:58PM  
Mar-17-22 07:00AM  
Jan-25-22 10:06AM  
08:21AM  
07:45AM  
Jan-20-22 08:47AM  
08:00AM  
Jan-18-22 08:00AM  
Jan-11-22 04:56AM  
Jan-10-22 08:00AM  
08:00AM  
08:00AM  
Dec-03-21 08:00AM  
Oct-19-21 08:00AM  
Oct-15-21 08:00AM  
Sep-15-21 09:26AM  
08:00AM  
08:00AM  
Aug-03-21 03:01PM  
Jul-15-21 02:03AM  
Jul-12-21 08:59AM  
08:00AM  
Jul-09-21 08:00AM  
Jun-22-21 04:00PM  
Jun-21-21 08:30AM  
May-26-21 08:00AM  
May-24-21 12:03PM  
11:57AM  
08:00AM  
May-13-21 07:00AM  
May-06-21 07:00AM  
Apr-23-21 11:35AM  
Apr-22-21 09:04AM  
07:00AM  
Apr-19-21 07:00AM  
Mar-31-21 07:00AM  
Jan-20-21 07:32AM  
06:00AM  
Jan-16-21 01:23AM  
Dec-21-20 06:00AM  
Dec-10-20 08:00AM  
Oct-16-20 08:00AM  
Oct-02-20 04:05PM  
Sep-29-20 09:00PM  
06:00AM  
Sep-08-20 03:00AM  
02:00AM  
Sep-02-20 08:00AM  
Sep-01-20 02:00AM  
02:00AM  
02:00AM  
Aug-31-20 06:05PM  
Aug-26-20 03:00AM  
02:00AM  
Aug-20-20 02:00AM  
Aug-05-20 11:04AM  
Jul-24-20 02:00AM  
Jul-17-20 06:20AM  
Jul-03-20 12:56PM  
Jun-25-20 11:25AM  
Jun-15-20 08:00AM  
Apr-29-20 08:00AM  
08:00AM  
Apr-15-20 08:00AM  
Mar-30-20 08:00AM  
08:00AM  
08:00AM  
Mar-24-20 04:00PM  
Feb-28-20 01:00PM  
Feb-26-20 09:15AM  
Feb-24-20 06:00AM  
Feb-10-20 08:00AM  
08:00AM  
Jan-03-20 05:38AM  
Nov-15-19 08:00AM  
Sep-19-19 08:10AM  
Sep-09-19 06:34AM  
06:00AM  
06:00AM  
Jul-11-19 08:00AM  
Jul-08-19 08:00AM  
Jun-26-19 11:05AM  
May-22-19 08:00AM  
May-15-19 09:00PM  
May-07-19 07:19AM  
May-06-19 08:00AM  
Apr-30-19 10:42AM  
Apr-24-19 08:00AM  
04:30AM  
04:30AM  
04:15AM  
Apr-15-19 09:55AM  
Apr-01-19 09:30AM  
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.